KALA BIO, Inc. (KALA) Q1 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kala Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.892 Good morning and welcome to Kala Pharmaceuticals' first quarter 2021 financial results 00:00:04.892 -- 00:00:08.995 conference call. At this time, all participants are in listen-only mode. 00:00:08.995 -- 00:00:13.598 Following management prepared remarks, a Q&A session will be held as a reminder. 00:00:13.598 -- 00:00:19.522 This call is being recorded. I would now like to turn the call over to Nairanjan Kamraswanan, 00:00:19.522 -- 00:00:22.564 Senior Vice President of Strategy for Kala Pharmaceuticals. 00:00:22.564 -- 00:00:24.465 Please proceed. 00:00:24.465 -- 00:00:29.247 Thank you, Operator, and thank you all for participating in today's call. 00:00:30.359 -- 00:00:35.403 Mark Iwiki, Chairman, President, and Chief Executive Officer, Todd Bazemore, 00:00:35.403 -- 00:00:40.947 Chief Operating Officer, Mary Remeth, Chief Financial Officer, and Kim Brazel, 00:00:40.947 -- 00:00:43.089 our Chief Medical Officer. 00:00:43.089 -- 00:00:48.252 Today's call is being webcast live. The webcast link can be found in the Investors 00:00:48.252 -- 00:00:52.514 and Media section of our website at www.calarx.com. 00:00:53.716 -- 00:00:58.435 During this call, we will be referring to non-GAAP financial measures which are not prepared 00:00:58.435 -- 00:01:02.118 in accordance with generally accepted accounting principles. 00:01:02.118 -- 00:01:06.862 Reconciliation of the non-GAAP financial measures to the most directly comparable GAAP 00:01:06.862 -- 00:01:11.966 measures is available in our press release issued today, which can also be found on our 00:01:11.966 -- 00:01:13.547 website. 00:01:13.547 -- 00:01:17.831 On this call, we will make certain comments about CALA's future expectations, plans, 00:01:17.831 -- 00:01:22.094 and prospects...